Homozygous cystathionine β-synthase deficiency, combined with factor V leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis

Blood

Volumn 91, Issue 6, 1998, Pages 2015-2018

  Kluijtmans, Leo A J ^a   Boers, Godfried H J ^a   Verbruggen, Bert ^a   Trijbels, Frans J M ^a   Nováková, Irena R O ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; CYSTATHIONINE BETA SYNTHASE; METHIONINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE MUTATION; GENETIC RISK; HOMOCYSTINURIA; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; INBORN ERROR OF METABOLISM; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; VEIN THROMBOSIS;

EID: 0032521543     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2015     Document Type: Article

References (40)

1. Finkelstein JD, Mudd HS, Laster FIK: Homocystinuria due to cysthathionine synthetase deficiency: The mode of inheritance. Science 146:785, 1964
2. Mudd HS, Uhlendorf BW, Freeman JM, Finkelstein JD, Shin VE: Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun 46:905, 1972
3. Mudd SH, Levy HL, Abeles RH: A derangement in B12 metabolism leading to homocystinuria, cystathioninemia and methylmalonuc aciduria. Biochem Biophys Res Commun 35:121, 1969
4. McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111, 1969
5. Mudd HS, Levy HL, Skovby F: Disorders of transsulfuration, in Scriver CR, Beaudet AL, Sly WS, Vall D (eds): The Metabolic and Molecular Basis of Inherited Disease. New York, NY, McGraw-Hill, 1995, p 1279
6. Mudd HS, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer L: The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 37:1, 1985
7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
8. Zöller B, Dahlbäck B: Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536, 1994
9. Koster T, Rosendaal FR, De Ronde H, Briët E, Vandenbroucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 342:1503, 1993
10. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85:1504, 1995
11. Ridker PM, Hennekens CH, Lindpainter K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912, 1995
12. Den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbroucke JP, Rosendaal FR: Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759, 1996
13. D'Angelo A, Fermo I, D'Angelo SV: Thrombophilia, homocystinuria, and mutation of the factor V gene. N Engl J Med 335:289, 1996 (letter)
14. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ: Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation 95:1777, 1997
15. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligsohn U: Coexistence of hereditary homocystinuria and factor V Leiden-effect on thrombosis. N Engl J Med 334:763, 1996
16. Quéré I, Lamarti H, Chadefaux-Vekemans B: Thrombophilia, homocystinuria, and mutation of the factor V gene. N Engl J Med 335:289, 1996 (letter)
17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, Den Heijer M, Kluijtmans LAJ, Van den Heuvel LPWJ, Rozen R: A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nature Genet 10:111, 1995
18. Kluijtmans LAJ, Van den Heuvel LPWJ, Boers GHJ, Stevens EMB, Frosst P, Van Oost BA, Trijbels JMF, Rozen R, Blom HJ: Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35, 1996
19. Arruda VR, Von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF: The mutation Ala677→Val in the methylenetetrahydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thromb Haemost 77:818, 1997
20. 506). Blood 88:285a, 1996 (abstr)
21. Boers GHJ, Fowler B, Smals AGH, Trijbels JMF, Leermakers AI, Kleijer WJ, Kloppenborg PWC: Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet 69:164, 1985
22. Fowler B, Kraus JP, Packman S, Rosenberg LE: Homocystinuria: Evidence for three distinct classes of cystathionine β-synthase mutant in cultured fibroblasts. J Clin Invest 61:645, 1978
23. Kluijtmans LAJ, Boers GHJ, Stevens EMB, Renier WO, Kraus JP, Trijbels JMF, Van den Heuvel LPWJ, Blom HJ: Defective cystathionine β-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest 98:285, 1996
24. Kluijtmans LAJ, Blom HJ, Boers GHJ, Van Oost BA, Trijbels JMF, Van den Heuvel LPWJ: Two novel missense mutations in the cystathionine β-synthase gene in homocystinuric patients. Hum Genet 96:249, 1995
25. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
26. Van der Locht LTF, Kuypers AWHM, Verbruggen BW, Linssen PCM, Nováková IRO, Mensink EJBM: Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis. Thromb Haemos 74:1276, 1995
27. Boers GHJ, Smals AGH, Trijbels JMF, Leermakers AI, Kloppenborg PWC: Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years. J Clin Invest 72:1971, 1983
28. Kluijtmans LAJ, Kastelein JJP, Lindemans J, Boers GHJ, Heil SG, Bruschke AVG, Jukema JW, Van den Heuvel LPWJ, Trijbels JMF, Boerma GJM, Verheugt FWA, Willems F, Blom HJ: Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 96:2573, 1997
29. Perry DJ, Pasi KJ: Resistance to activated protein C and factor V Leiden. Q J Med 90:379, 1997
30. Laffan MA, Tuddenham EGD: Inherited thrombophilia. Q J Med 90:375, 1997
31. Svennson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
32. Falcon CR, Cattaneo M, Panzeri D, Martinelli I, Mannuci PM: High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb 14:1080, 1994
33. Den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ: Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet 345:882, 1995
34. Brattström L, Tengborn L, Lagerstedt C, Israelsson B, Hultberg BL: Plasma homocysteine in venous thrombosis. Haemostasis 21:51, 1991
35. Amundsen T, Ueland PM, Waage A: Plasma homocysteine levels in patients with deep venous thrombosis. Arterioscler Thromb Vasc Biol 15:1321, 1995
36. Bienvenu T, Ankri A, Chadefaux B, Montalescot G, Kamoun P: Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters. Thromb Res 70:123, 1993
37. Trillot N, Preudhomme C, Alhenc-Gelas M, Gaveriaux V, Bauters A, Gandrille S, Aiach M, Jude B: Thermolabile methylenetetrahydrofolate reductase (MTHFR) does not modify the risk for thromboembolism in subjects with heterozygous factor V Leiden. Blood 88:284a, 1996 (abstr)
38. Finkelstein JD, Martin JJ: Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem 259:9508, 1984
39. Selhub J, Miller JW: The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131, 1992
40. Applegarth DA, Hardwick DF, Ingram F, Auckland NL, Bozoian G: Excretion of S-adenosylmethionine and S-adenosylhomocysteine in homocystinuria. N Engl J Med 285:1265, 1971